Phase I trial of daily pomalidomide in patients with advanced solid tumors

被引：3
|
作者：
Cooney, M. M.
Bokar, J. A.
Dreicer, R.
Krishnamurthi, S. S.
Savvides, P.
Nock, C. J.
Rodal, M. B.
Henderson, L.
Dowlati, A.
机构：
[1] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[3] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13077
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
  • [22] Phase I trial of imexon (IMX) in patients (pts) with advanced solid tumors
    Dragovich, T
    Mendelson, D
    Gordon, M
    Long, K
    Downhour, M
    Dorr, R
    Hersh, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 229S - 229S
  • [23] A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
    Liu, Stephen V.
    Groshen, Susan G.
    Kelly, Karen
    Reckamp, Karen L.
    Belani, Chandra
    Synold, Timothy W.
    Goldkorn, Amir
    Gitlitz, Barbara J.
    Cristea, Mihaela C.
    Gong, I-Yeh
    Semrad, Thomas J.
    Xu, Yucheng
    Xu, Tong
    Koczywas, Marianna
    Gandara, David R.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 723 - 732
  • [24] Phase I dose escalation trial of pegzilarginase in patients with advanced solid tumors
    Rasco, Drew W.
    Eckhardt, S. Gail
    Davar, Diwakar
    Lewis, Karl
    Lara-Guerra, Humberto
    Alters, Susan E.
    Eckert, Stephen
    Rowlinson, Scott W.
    Wooldridge, James E.
    Carvajal, Richard D.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] A Phase I Trial of Bexarotene in Combination With Docetaxel in Patients With Advanced Solid Tumors
    Malik, Shakun M.
    Collins, Brian
    Pishvaian, Michael
    Ramzi, Pari
    Marshall, John
    Hwang, Jimmy
    CLINICAL LUNG CANCER, 2011, 12 (04) : 231 - 236
  • [26] Phase I trial of bortezomib in combination with ocetaxel in patients with advanced solid tumors
    Messersmith, WA
    Baker, SD
    Lassiter, L
    Sullivan, RA
    Dinh, K
    Almuete, VI
    Wright, JJ
    Donehower, RC
    Carducci, MA
    Armstrong, DK
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1270 - 1275
  • [27] Phase I trial of irinotecan and epirubicin in patients with advanced solid tumors.
    Gold, PJ
    Refice, S
    West, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 164S - 164S
  • [28] A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
    Yannis Metaxas
    Carmen Kahatt
    Vicente Alfaro
    Salvador Fudio
    Ali Zeaiter
    Ruth Plummer
    Cristiana Sessa
    Roger Von Moos
    Martin Forster
    Anastasios Stathis
    Investigational New Drugs, 2022, 40 : 91 - 98
  • [29] A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
    Metaxas, Yannis
    Kahatt, Carmen
    Alfaro, Vicente
    Fudio, Salvador
    Zeaiter, Ali
    Plummer, Ruth
    Sessa, Cristiana
    Von Moos, Roger
    Forster, Martin
    Stathis, Anastasios
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 91 - 98
  • [30] Phase I trial of combination becatecarin and oxaliplatin in patients with advanced solid tumors
    Manda, S.
    Mauser, C.
    Bokar, J.
    Cooney, M.
    Brell, J.
    Krishnamurthi, S.
    Savvides, P.
    Ivy, P.
    Remick, S.
    Dowlati, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345